Mallinckrodt Hospital Products Inc. recalls Terlivaz (terlipressin for injection)
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.
- Products
-
- Terlivaz (terlipressin for injection)
- Where it was sold
-
USA nationwide
Nationwide
- Units affected
- 421 vials involved in this recall (2,448 vials distributed)
- About this recall
- Terlivaz (terlipressin for injection), 0.85mg/vial, Single-Dose Vial, Rx only, Distributed by: Mallinckrodt Hospital Products Inc., Bridgewater, NJ 08807, USA, NDC 43825-200-01